TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Taubert medicin AB
Closing information (x1000 EUR)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
158
|
93
|
20 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
11
|
3
|
-7 |
| EBITDA |
11
|
3
|
-7 |
| Total assets |
36
|
26
|
13 |
| Current assets |
36
|
26
|
13 |
| Current liabilities |
21
|
19
|
10 |
| Equity capital |
14
|
6
|
3 |
| - share capital |
4
|
4
|
5 |
| Employees (average) |
2
|
2
|
1 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
38.9%
|
23.1%
|
23.1% |
| Turnover per employee |
79
|
46
|
20 |
| Profit as a percentage of turnover |
7.0%
|
3.2%
|
-35.0% |
| Return on assets (ROA) |
30.6%
|
11.5%
|
-53.8% |
| Current ratio |
171.4%
|
136.8%
|
130.0% |
| Return on equity (ROE) |
78.6%
|
50.0%
|
-233.3% |
| Change turnover |
68
|
75
|
-7 |
| Change turnover % |
76%
|
422%
|
-26% |
| Chg. No. of employees |
0
|
1
|
1 |
| Chg. No. of employees % |
0%
|
100% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.